Insider Stock Trading History of Roberts Margo R


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Roberts Margo R since year 2005. The trader's CIK number is 1609643. At the time of this reporting, Roberts Margo R is the Chief Scientific Officer of Kite Pharma, Inc. . (stock ticker symbol KITE). See this page for all insider trading activities at Kite Pharma, Inc. .


Stock purchases, sales, and option exercises reported by insider Roberts Margo R since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-03-15 KITE Kite Pharma, Inc. Sale 8,506 46.40 394,703
2016-03-15 KITE Kite Pharma, Inc. Option Ex 8,506 8.85 75,278
2016-02-12 KITE Kite Pharma, Inc. Option Ex 18,750 .70 13,125
2016-02-12 KITE Kite Pharma, Inc. Sale 18,750 64.16 1,202,962
2016-01-15 KITE Kite Pharma, Inc. Sale 6,145 55.34 340,082
2016-01-15 KITE Kite Pharma, Inc. Option Ex 6,145 8.85 54,383
2015-12-15 KITE Kite Pharma, Inc. Option Ex 6,145 8.85 54,383
2015-12-15 KITE Kite Pharma, Inc. Sale 6,145 64.00 393,280
2015-11-16 KITE Kite Pharma, Inc. Option Ex 6,145 8.85 54,383
2015-11-16 KITE Kite Pharma, Inc. Sale 6,145 78.26 480,907
2015-10-15 KITE Kite Pharma, Inc. Sale 6,145 62.47 383,865
2015-10-15 KITE Kite Pharma, Inc. Option Ex 6,145 8.85 54,383
2015-09-15 KITE Kite Pharma, Inc. Sale 6,145 64.32 395,246
2015-09-15 KITE Kite Pharma, Inc. Option Ex 6,145 8.85 54,383
2015-08-17 KITE Kite Pharma, Inc. Option Ex 6,145 8.85 54,383
2015-08-17 KITE Kite Pharma, Inc. Sale 6,145 60.93 374,414
2015-07-15 KITE Kite Pharma, Inc. Sale 22,167 71.66 1,588,442
2015-07-15 KITE Kite Pharma, Inc. Option Ex 22,167 8.85 196,177
2015-06-15 KITE Kite Pharma, Inc. Option Ex 8,625 .70 6,037
2015-06-15 KITE Kite Pharma, Inc. Sale 8,625 56.97 491,392
2015-05-15 KITE Kite Pharma, Inc. Option Ex 8,625 .70 6,037
2015-05-15 KITE Kite Pharma, Inc. Sale 8,625 50.92 439,185

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Roberts Margo R (Chief Scientific Officer of Kite Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.